본문 바로가기
KERD
논문KCI 등재

Foxf2 represses bone formation via Wnt2b/β-catenin signaling

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Differentiation of mesenchymal stem cells (MSCs) into osteoblasts is a critical process for proper skeletal development and acquisition/maintenance of bone mass. However, since this regulatory mechanism has not yet been fully elucidated, the treatment of severe osteoporosis and fractures is a challenge. Here, through a comprehensive analysis of gene expression during the differentiation of MSCs into osteoblasts, we show that the forkhead transcription factor Foxf2 is a crucial regulator of this process. Foxf2 expression transiently increased during MSC osteoblastic differentiation. Overexpression of Foxf2 in MSCs inhibited osteoblastic differentiation, and conversely, knockdown of Foxf2 expression promoted this process. Osteoprogenitor-specific Foxf2 knockout mice developed a high bone mass phenotype due to increased bone formation. RNA-seq analysis and molecular experiments revealed that Foxf2 regulation of bone formation is mediated by Wnt2b. Knockdown of Foxf2 in mouse femurs enhanced bone regeneration in vivo. FOXF2 expression was correlated with hip bone mineral density in postmenopausal women with low bone mass. Finally, inhibition of FOXF2 promoted osteoblastic differentiation of human MSCs. This study uncovers a critical role of Foxf2 in the differentiation of MSCs into osteoblasts and provides insight into the pathogenesis associated with bone-related diseases such as osteoporosis and nonunion after fracture

Abstract

Differentiation of mesenchymal stem cells (MSCs) into osteoblasts is a critical process for proper skeletal development and acquisition/maintenance of bone mass. However, since this regulatory mechanism has not yet been fully elucidated, the treatment of severe osteoporosis and fractures is a challenge. Here, through a comprehensive analysis of gene expression during the differentiation of MSCs into osteoblasts, we show that the forkhead transcription factor Foxf2 is a crucial regulator of this process. Foxf2 expression transiently increased during MSC osteoblastic differentiation. Overexpression of Foxf2 in MSCs inhibited osteoblastic differentiation, and conversely, knockdown of Foxf2 expression promoted this process. Osteoprogenitor-specific Foxf2 knockout mice developed a high bone mass phenotype due to increased bone formation. RNA-seq analysis and molecular experiments revealed that Foxf2 regulation of bone formation is mediated by Wnt2b. Knockdown of Foxf2 in mouse femurs enhanced bone regeneration in vivo. FOXF2 expression was correlated with hip bone mineral density in postmenopausal women with low bone mass. Finally, inhibition of FOXF2 promoted osteoblastic differentiation of human MSCs. This study uncovers a critical role of Foxf2 in the differentiation of MSCs into osteoblasts and provides insight into the pathogenesis associated with bone-related diseases such as osteoporosis and nonunion after fracture

참고문헌 (48)

  1. Florencio-Silva, R., "Biology of bone tissue : structure, function, and factors that influence bone cells", Biomed. Res. Int, 2015, pp.421746~ (2015)
  2. Long, F., "Development of the endochondral skeleton", Cold Spring Harb. Perspect. Biol, 5, pp.a008334~ (2013)
  3. Manolagas, S. C., "Wnt signaling and osteoporosis", Maturitas, 78, pp.233~237 (2014)
  4. Baron, R., "Targeting the Wnt", β-catenin pathway to regulate bone formation in the adult skeleton, 2007, pp.148, 2635~2643
  5. MacDonald, B. T., "Frizzled and LRP5", 6 receptors for Wnt, Cold Spring Harb. Perspect. Biol, pp.2012, 4[DOI]
  6. van Dinther, M., "Anti-sclerostin antibody inhibits internalization of sclerostin and sclerostin-mediated antagonism of Wnt", LRP6 signaling, 2013, pp.8, e62295~
  7. Cosman, F., "Romosozumab treatment in postmenopausal women with osteoporosis", N. Engl. J. Med, 375, pp.1532~1543 (2016)
  8. Semënov, M., "SOST is a ligand for LRP5", LRP6 and a Wnt signaling inhibitor, 2005, pp.280, 26770~26775
  9. Asadipooya, K., "Cardiovascular outcomes of romosozumab and protective role of Alendronate", Arterioscler. Thromb. Vasc. Biol, 39, pp.1343~1350 (2019)
  10. Ensrud, K. E., "Epidemiology of fracture risk with advancing age", J. Gerontol. A Biol. Sci. Med. Sci, 68, pp.1236~1242 (2013)
  11. Inose, H., "Risk factors of nonunion after acute osteoporotic vertebral fractures: a prospective multicenter cohort study", Spine (Philos. Pa 1976), 45, pp.895~902 (1976)
  12. Aitola, M., "Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions", Dev. Dyn, 218, pp.136~149 (2000)
  13. Wang, S., "FOXF2 reprograms breast cancer cells into bone metastasis seeds", Nat. Commun, 10, pp.2707~ (2019)
  14. Xu, J., "Genome-wide Identification of Foxf2Target Genes in Palate Development", J. Dent. Res, 99, pp.463~471 (2020)
  15. Reyahi, A., "Foxf2 is required for brain pericyte differentiation and development and maintenance of the blood-brain barrier", Dev. Cell, 34, pp.19~32 (2015)
  16. Logan, M., "Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer", Genesis, 33, pp.77~80 (2002)
  17. David E. Maridas, "Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice", Journal of Visualized Experiments, (131) (2018), MyJove Corporation[DOI]
  18. Dempster, D. W., "Standardized nomenclature, symbols, and units for bone histomorphometry : a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee", J. Bone Miner. Res, 28, pp.2~17 (2013)
  19. Mulati, M., "The long noncoding RNA Crnde regulates osteoblast proliferation through the Wnt", β-catenin signaling pathway in mice, 2020, pp.130, 115076~
  20. Yamada, T., "After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate", Bone, 57, pp.343~354 (2013)
  21. Fukuda, T., "MicroRNA-145 regulates osteoblastic differentiation by targeting the transcription factor Cbfb", FEBS Lett, 589, pp.3302~3308 (2015)
  22. Yamaguchi, A., "Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2", PA6, 1996, pp.220, 366~371
  23. Wu, M., "TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease", Bone Res, 4, pp.16009~ (2016)
  24. Uppal, S., "Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy", Nat. Genet, 40, pp.789~793 (2008)
  25. Shibata, Y., "Role of a new member of IGFBP superfamily, IGFBP-rP10, in proliferation and differentiation of osteoblastic cells", Biochem. Biophys. Res. Commun, 325, pp.1194~1200 (2004)
  26. Wang, T., "Forkhead transcription factor Foxf2(LUN)-deficient mice exhibit abnormal development of secondary palate", Dev. Biol, 259, pp.83~94 (2003)
  27. Cserjesi, P., "MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer", Development, 115, pp.1087~1101 (1992)
  28. Wang, C., "NOTCH signaling in skeletal progenitors is critical for fracture repair", J. Clin. Invest, 126, pp.1471~1481 (2016)
  29. Greenbaum, A., "CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance", Nature, 495, pp.227~230 (2013)
  30. Moore, E. R., "Periosteal progenitors contribute to load-induced bone formation in adult mice and require primary cilia to sense mechanical stimulation", Stem Cell Res. Ther, 9, pp.190~ (2018)
  31. Kuo, T. -R., "Bone biomarker for the clinical assessment of osteoporosis:recent developments and future perspectives", Biomark. Res, 5, pp.18~ (2017)
  32. Oryan, A., "Role of mesenchymal stem cells in bone regenerative medicine: what is the evidence?", Cells Tissues Organs, 204, pp.59~83 (2017)
  33. Inose, H., "Bone turnover markers as a new predicting factor for nonunion after spinal fusion surgery", Spine (Philos. Pa 1976), 43, pp.E29~E34 (1976)
  34. Takahashi, A., "Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone", J. Biol. Chem, 293, pp.19387~19399 (2018)
  35. Gerin, I., "On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake", J. Biol. Chem, 284, pp.10755~10763 (2009)
  36. Ormestad, M., "Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production", Development, 133, pp.833~843 (2006)
  37. Jia, B., "Long noncoding RNA LINC00707 sponges miR-370-3p to promote osteogenesis of human bone marrow-derived mesenchymal stem cells through upregulating WNT2B", Stem Cell Res. Ther, 10, pp.67~ (2019)
  38. Hellqvist, M., "Differential activation of lung-specific genes by two forkhead proteins, FREAC-1 and FREAC-2", J. Biol. Chem, 271, pp.4482~4490 (1996)
  39. Meyer-Schaller, N., "Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration", Breast Cancer Res, 20, pp.118~ (2018)
  40. Kang, L. J., "Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness", Faseb J, 33, pp.6564~6573 (2019)
  41. Lam, E. W., "Forkhead box proteins : tuning forks for transcriptional harmony", Nat. Rev. Cancer, 13, pp.482~495 (2013)
  42. Reynolds, K., "Wnt signaling in orofacial clefts: crosstalk, pathogenesis and models", Dis. Model. Mech, 12, pp.dmm037051~ (2019)
  43. Medio, M., "Wnt", β-catenin signaling and Msx1 promote outgrowth of the maxillary prominences, 2012, pp.3, 375~
  44. Yan, J., "Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone", Am. J. Pathol, 181, pp.234~244 (2012)
  45. Kósa, J. P., "Effect of menopause on gene expression pattern in bone tissue of nonosteoporotic women", Menopause, 16, pp.367~377 (2009)
  46. Saad, M. A., "Could procollagen type I N-terminal propeptide (PINP) and bone alkaline phosphatase (B-ALP) be valid alternative diagnostic markers to dual X-ray absorptiometry (DEXA) in elderly females with osteoporosis? An Egyptian radiological and laboratory monocentric study", Egypt. Rheumatol. Rehabil, 48, pp.20~ (2021)
  47. Tehrani, S. S., "Status of circulating bone turnover markers in elderly osteoporosis", osteopenia patients in comparison with healthy subjects, 2020, pp.14, 97~106
  48. Finnes, T. E., "Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study", Bone, 64, pp.1~7 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (191건)